Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 5.17 % |
3 Month Return | + 35.29 % |
1 Year Return | + 49.89 % |
Market Stats | |
Previous Close | ₹48.25 |
Open | ₹47.29 |
Volume | 359.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹18.05Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹18.05 Cr |
P/B Ratio | 178 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹18.05 Cr | 28.42% | 0.99 | NA | NA | |
NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
Organisation | Parmax Pharma Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Parmax Pharma Ltd
Parmax Pharma's standalone net sales for March 2024 stood at Rs 4.26 crore, down 33.29% YoY. The company reported a loss of Rs 1.45 crore in the same period.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, Parmax Pharma stock has moved up by 35.3%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 12.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 30.80% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 114.6%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 69.20% of holdings in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 30.8% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 69.2% | 0.00 | |
Others | 0% | 0.00 |
Parmax Pharma Ltd’s net profit jumped 83.94% since last year same period to ₹0.22Cr in the Q2 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -2300% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Parmax Pharma Ltd is currently in a Bullish trading position according to technical analysis indicators.
Parmax Pharma Ltd (540359) share price today is ₹46
Parmax Pharma Ltd is not listed on NSE
Parmax Pharma Ltd is listed on BSE
Today’s traded volume of Parmax Pharma Ltd(540359) is 359.00.
Today’s market capitalisation of Parmax Pharma Ltd(540359) is ₹18.05Cr.
Parmax Pharma Ltd(540359 | Price |
---|---|
52 Week High | ₹54 |
52 Week Low | ₹24.18 |
Parmax Pharma Ltd(540359) share price is ₹46. It is down -14.81% from its 52 Week High price of ₹54
Parmax Pharma Ltd(540359) share price is ₹46. It is up 90.24% from its 52 Week Low price of ₹24.18
Parmax Pharma Ltd(540359 | Returns |
---|---|
1 Day Returns | -2.25% |
1 Month Returns | 5.17% |
3 Month Returns | 35.29% |
1 Year Returns | 49.89% |